Clinical trial • Phase I • Neurology
NRG5051 for Parkinson's disease | Amyotrophic lateral sclerosis
Phase I trial of NRG5051 for Parkinson's disease | Amyotrophic lateral sclerosis. 118 participants.
Overview
- Trial Therapeutic Area
- Neurology
- Trial Disease
- Parkinson's disease | Amyotrophic lateral sclerosis
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 06-10-2025
- First CTIS Authorization Date
- 17-11-2025
Trial design
Phase I trial across 1 site in Netherlands.
- Target Sample Size
- 118
Eligibility
Recruits 118 Vulnerable population not selected (isVulnerablePopulationSelected=false); no consent or assent handling information provided in the record..
- Vulnerable Population
- Vulnerable population not selected (isVulnerablePopulationSelected=false); no consent or assent handling information provided in the record.
Recruitment
- Planned Sample Size
- 118
- Recruitment Window Months
- 11
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 118
Netherlands
- Earliest CTIS Part Ii Submission Date
- 12-11-2025
- Latest Decision Or Authorization Date
- 10-03-2026
- Processing Time Days
- 118
- Number Of Sites
- 1
- Number Of Participants
- 118
Sites
- Site Name
- Centre for Human Drug Research
- Department Name
- Neurology
- Contact Person Name
- Philip Kremer
- Contact Person Email
- cta@chdr.nl
Sponsor
Primary sponsor
- Full Name
- Nrg Therapeutics Limited
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- United Kingdom
Investigational products
- Investigational Product Name
- NRG5051
Related trials
Other published trials that may interest you.
- OCRELIZUMAB for Relapsing multiple sclerosis | Relapsing-remitting multiple sclerosis | Secondary progressive multiple sclerosis (active)
- CENOBAMATE for Partial-onset (focal) seizures
- Ocrelizumab for Relapsing multiple sclerosis | Relapsing-remitting multiple sclerosis | Active secondary progressive multiple sclerosis
- Clinical trial in Parkinson's disease
- Tenecteplase for Acute ischaemic stroke due to basilar artery occlusion | Posterior circulation ischaemic stroke